Blumberg Institute
@BlumbergInstit1
The Blumberg Institute is the nation’s leading translational research organization dedicated to finding a cure for hepatitis B and liver cancer in our lifetime.
ID:1262567094484377601
19-05-2020 02:14:00
1,1K Tweets
453 Followers
211 Following
The Philadelphia Business Journal just named Louis Kassa, CEO of the Hep B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center, to its 2024 Power 100 list for his influential role in the region's biotech industry!
Read more here: pabiotechbc.org/news-and-event…
GBR interviewed Lou Kassa, CEO of the Hep B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center, about the PABC's 2023 highlights, their strategies to help companies succeed past the incubator stage, the main priorities in 2024 and more!
Read it here: gbreports.com/interview/loui…
Today, the Hep B Foundation hosted the Blumberg Prize Seminar featuring the 2024 Blumberg Prize recipient, Dr. T. Jake Liang. Thank you to all who attended!
The online auction is a great way to support the Hep B Foundation's Annual Gala from the comfort of your own home! Bidding is now open and will close at 10 p.m. EDT tomorrow, April 5.
Check out the catalog here: events.readysetauction.com/hepatitisbfoun…
The Philadelphia Business Journal just named Lou Kassa, CEO of the Hep B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center, to its 2024 Power 100 list for his influential role in the region's biotech industry! Read more here: pabiotechbc.org/news-and-event…
The AIZ program was created to directly support early stage #lifesciences companies and academic technologies by providing funding, lab space, supplies and staffing help at both the PABC and B+labs life sciences #incubators .
More here: pabiotechbc.org/news-and-event…
Join the Hep B Foundation as they celebrate all of the wins for those living with hepatitis B over the past year, with a focus on expanding access to testing, vaccination & treatment. Learn more here: hepbgala.org
Happy #NationalVaccinationDay ! Baruch S. Blumberg, MD, DPhil, identified the hepatitis B virus and created the first vaccine to prevent infection!
Read more about Baruch S. Blumberg here: blumberginstitute.org/about/about-dr…
It’s #CelebrateScientistsDay ! We want to use this time to celebrate the scientists working today in our facilities and the scientists of tomorrow in our education programs!
Happy #ScienceEducationDay ! The Hepatitis B Foundation, Blumberg Institute and PABC are committed to training future generations of scientists through academic programs!
Learn more here: blumberginstitute.org/education-and-…
Lou Kassa, CEO of the Hep B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center, will be part of a panel tomorrow on “The Business Case for Health Equity,” hosted by Bernstein Private Wealth Management, BakerHostetler LLP and Syridex Bio.
Register here: info.bernstein.com/l/546252/2024-…
Lou Kassa, CEO of the Hep B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center, was recognized on Philadelphia Business Journal’s Power 100 list for 2024, commending his significant impact on the region’s business community!
Read more here: bizjournals.com/philadelphia/n…